Exploring the role of Orexin-A neuropeptide in Parkinson's disease: A systematic review and meta-analysis
- 12 May 2024
- journal article
- research article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 242, 108320
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potentialNeurochemistry International, 2020
- Orexin/Hypocretin Signaling2016
- Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's diseaseNeuroscience Letters, 2014
- Central functions of the orexinergic systemNeuroscience Bulletin, 2013
- Anti-Parkinson Drugs and Orexin Neurons2012
- Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depressionJournal of Neurology, 2009
- Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's diseaseClinical Neurology and Neurosurgery, 2009
- CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degenerationJournal of the Neurological Sciences, 2006
- Parkinsonism with excessive daytime sleepinessJournal of Neurology, 2005
- The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other HypersomniasArchives of Neurology, 2002